How should I taper off Gabapentin (gabapentin)?

Short half-life with non-linear absorption. Multiple daily doses needed. Water titration method works well for precise reductions. Reduce by no more than 10% per step. Non-linear pharmacokinetics mean absorption decreases at higher doses. Capsules can be opened for water titration.

Forums/Drug Profiles/

Gabapentin Tapering Guide

gabapentin

GabapentinoidFDA 1993

Go to Community Forum

Boxed Warning

Respiratory depression risk when used with CNS depressants, particularly opioids. Increased risk of suicidal thoughts and behavior (anticonvulsant class warning).

Overview

Gabapentin is an anticonvulsant approved for epilepsy (adjunctive therapy for partial seizures) and postherpetic neuralgia. It is widely prescribed off-label for neuropathic pain, anxiety, insomnia, and alcohol/benzodiazepine withdrawal. Despite its name, it does not bind GABA receptors.

Common Doses

100mg, 300mg, 600mg, 800mg

Formulations

Capsules: 100mg, 300mg, 400mg; Tablets: 600mg, 800mg; Oral solution: 250mg/5mL; Extended-release tablets (Gralise): 300mg, 600mg

Pregnancy

Category C (risk cannot be ruled out)

Mechanism of Action

Binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and subsequent release of excitatory neurotransmitters (glutamate, norepinephrine, substance P). Does not bind GABA receptors or affect GABA uptake/metabolism.

Taper Notes

Short half-life with non-linear absorption. Multiple daily doses needed. Water titration method works well for precise reductions.

Hyperbolic Tapering Guidance

Reduce by no more than 10% per step. Non-linear pharmacokinetics mean absorption decreases at higher doses. Capsules can be opened for water titration.

Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.

Common Withdrawal Symptoms

anxietyinsomnianauseasweatingseizure risk at high dosespain rebound

Interactions & Safety

Drug Interactions

Opioids — increased risk of respiratory depression and sedation
CNS depressants — additive sedation
Antacids containing aluminum/magnesium reduce gabapentin absorption by ~20% — dose gabapentin ≥2 hours after antacids

Food Interactions

Food modestly increases absorption (~14%)
Avoid alcohol (additive CNS depression)

Contraindications

Known hypersensitivity to gabapentin

Toxicity

Relatively low acute toxicity. Respiratory depression when combined with opioids or CNS depressants. Suicidal ideation (class warning for anticonvulsants). Physical dependence with chronic high-dose use.

Pharmacokinetics

ADME Profile

Absorption

Absorbed via L-amino acid transport system in the small intestine. Bioavailability is dose-dependent (inversely proportional): ~60% at 300mg, ~35% at 1600mg. Tmax 2–3 hours. Food modestly increases absorption.

Distribution

~0.8 L/kg (58 L in 72 kg individual)

Metabolism

Not appreciably metabolized in humans. No CYP involvement. Excreted unchanged.

Elimination

Renal (~100% excreted unchanged). Clearance is proportional to creatinine clearance.

Protein Binding

<3% (not significantly protein bound)

Clearance

~120–130 mL/min (renal clearance, similar to GFR)

Need a clinician who understands tapering?

Browse our map of deprescribing-informed providers worldwide.

Find a Deprescriber

Other Drug Profiles

Lexapro

escitalopram — SSRI

Zoloft

sertraline — SSRI

Paxil

paroxetine — SSRI

Prozac

fluoxetine — SSRI

Sources & References

Gabapentin (gabapentin) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.

Encyclopedic & chemical databases

Neutral, high-authority entity references.

Wikipedia entry for gabapentin

Peer-reviewed research

Primary literature cited in this taper guide.

Davies J, Read J 2019 — A systematic review into the incidence, severity and duration of antidepressant withdrawal effects (Addictive Behaviors)
Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)

Clinical guidelines

Evidence-based deprescribing and prescribing standards.

Deprescribing-specific resources

Clinician-facing references on tapering protocols.

Deprescribing.org — Evidence-based deprescribing algorithms
Royal College of Psychiatrists — Pregabalin and gabapentin — UK clinical guidance on pregabalin and gabapentin prescribing

Patient-advocacy & lived-experience

Long-running communities documenting withdrawal experience.

Surviving Antidepressants — tapering forum — Long-running community archive of antidepressant taper experiences
Inner Compass Initiative — Withdrawal Project — Peer-led resources for psychiatric drug withdrawal
Mad in America — antidepressant withdrawal archive — Journalism and personal narratives on SSRI/SNRI discontinuation
RxISK — adverse drug reaction reporting — Independent database of patient-reported adverse effects

TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.